What Trump’s new tariffs means for pharmaceuticals and ‘patented’ drugs The Washington Post Trump Will Slap Tariffs on Imported Drugs, Trucks and Household Furnishings The New York Times Trump’s pharma tariffs could raise drug prices for consumers, but exemptions may blunt impact NBC News Trump announces a 25% tariff on trucks and a 30% tariff on furniture CNN Trump’s 100% tariffs on pharmaceuticals will …
Read More »Tag Archives: Pharmaceuticals
Trump announces new tariffs on trucks, furniture and pharmaceuticals – The Washington Post
Trump announces new tariffs on trucks, furniture and pharmaceuticals The Washington Post A 100% tariff on some imported drugs is coming October 1, Trump says CNN Trump announces ‘national security’ tariffs on drugs, trucks, furniture Al Jazeera European Stocks Gain as Investors Shrug Off Trump’s Tariff Plans Bloomberg.com Trump’s New 100% Tariff On Patented Drugs Triggers Slide In Asian Pharma Stocks Forbes Source link
Read More »Trump announces tariffs on pharmaceuticals, furniture and heavy trucks beginning Oct. 1 – The Hill
Trump announces tariffs on pharmaceuticals, furniture and heavy trucks beginning Oct. 1 The Hill Trump announces a 25% tariff on trucks and a 30% tariff on furniture CNN Exclusive | Trump Takes Aim at Chip Makers With New Plan to Throttle Imports The Wall Street Journal Trump Will Slap Tariffs on Imported Drugs, Trucks and Household Furnishings The New York Times Asian Stocks to …
Read More »New US tariffs hit pharmaceuticals, cabinets, furniture and trucks
WASHINGTON (AP) — President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on Oct. 1. The posts on his social media site showed that Trump’s devotion to tariffs did not end with the trade frameworks and …
Read More »AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline
AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline Gilgamesh’s lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder (MDD). Bretisilocin is a novel, short-acting serotonin (5-HT)2A receptor agonist and 5-HT releaser. NORTH CHICAGO, Ill. and NEW YORK, Aug. …
Read More »What’s Going On With Tonix Pharma Stock Monday? – Tonix Pharmaceuticals (NASDAQ:TNXP)
On Friday, the U.S. Food and Drug Administration (FDA) approved Tonix Pharmaceuticals Holding Corp.’s TNXP Tonmya (cyclobenzaprine HCl sublingual tablets) for fibromyalgia in adults. Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and other symptoms like sleep disturbances and cognitive difficulties. Tonmya is a non-opioid, once-daily bedtime analgesic with a unique sublingual (under the tongue) formulation that is …
Read More »Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply | Pharmaceuticals industry
Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of US tariffs, prompting it to cut costs and sharpen its commercial focus. The Danish drugmaker, whose booming sales of GLP-1 diabetes and obesity drugs in recent years had turned it into Europe’s most valuable company, has lost nearly $100bn (£75bn) in …
Read More »